Proteomic Profiling Defines Vascular Cell States
Label-free LC–MS profiles nearly 5,000 cells, resolving smooth muscle subtypes and disease-associated phenotypes
False
Label-free LC–MS profiles nearly 5,000 cells, resolving smooth muscle subtypes and disease-associated phenotypes
To characterize cell states in complex vascular tissue using a label-free single-cell proteomics workflow, enhancing the understanding of disease-associated heterogeneity.
The study reveals significant proteomic changes in vascular cells associated with Marfan syndrome, suggesting potential biomarkers for disease progression.
Multi-omic approaches combining transcriptomic and proteomic data can enhance understanding of cellular states and their role in aneurysm progression, paving the way for future research into targeted therapies.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

False
False
December 2, 2024
4 min read
Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards
December 5, 2024
6 min read
Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards
December 9, 2024
1 min read
TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy
December 11, 2024
10 min read
Meet the products – and the experts – defining analytical innovation in 2024
Affiliations:
Specialties:
Areas of Expertise:
False